U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Carcinoma with Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy Regimens
2008 ◽
Vol 14
(5)
◽
pp. 1296-1302
◽
2009 ◽
Vol 29
(1)
◽
pp. 167-174
◽
2011 ◽
Vol 31
(3)
◽
pp. 225-232
2006 ◽
Vol 1
(2)
◽
pp. 113-118
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3711-3711
2005 ◽
Vol 11
(4)
◽
pp. 1368-1371
◽
2007 ◽
Vol 0
(0)
◽
pp. 070817144921004-???
◽